Switch to: References

Add citations

You must login to add citations.
  1. Should vaccination status be a consideration during secondary triage?Isaac Jarratt Barnham - forthcoming - Journal of Medical Ethics.
    The rapid development of widely available and effective vaccines has been integral to the international response to the COVID-19 pandemic. However, a significant minority of those offered vaccination have refused, often due to their adherence to ‘anti-vax’ beliefs. These beliefs include that vaccines are dangerous, render the recipient magnetic or contain government microchips.During the pandemic, numerous calls were made for those voluntarily refusing vaccination to be deprioritised when allocating scarce healthcare resources. While these calls were rejected, the likelihood of the (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Artificial Intelligence for Clinical Decision-Making: Gross Negligence Manslaughter and Corporate Manslaughter.Helen Smith - forthcoming - The New Bioethics:1-15.
    This paper discusses the risk of gross negligence manslaughter (GNM) and corporate manslaughter charges (CM) when clinicians use an artificially intelligent system’s (AIS’s) outputs in their practice. I identify the elements of these offenses within the context of the law of England and Wales and explore how they could be applied in a potential scenario where a patient's death has followed AIS use by a clinician. The risk of a conviction due to making an AIS-augmented workplace mistake highlights the non-trivial (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Using Artificial Intelligence in Patient Care—Some Considerations for Doctors and Medical Regulators.Kanny Ooi - 2024 - Asian Bioethics Review 16 (3):483-499.
    This paper discusses the key role medical regulators have in setting standards for doctors who use artificial intelligence (AI) in patient care. Given their mandate to protect public health and safety, it is incumbent on regulators to guide the profession on emerging and vexed areas of practice such as AI. However, formulating effective and robust guidance in a novel field is challenging particularly as regulators are navigating unfamiliar territory. As such, regulators themselves will need to understand what AI is and (...)
    Download  
     
    Export citation  
     
    Bookmark